#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive chronic myeloid leukaemia Lip and/or oral cavity cancer Ovarian cancer stage III Peripheral T-cell lymphoma unspecified Arginase deficiency SAPHO syndrome Neuroblastoma Friedreich's ataxia Diabetes insipidus Liposarcoma recurrent Mitochondrial DNA depletion Malignant neoplasm of choroid Leiomyosarcoma metastatic Metastatic malignant melanoma Fungal infection More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Treatment Glycogen storage disease type I – Life with Disease Nephroblastoma – Trials in Disease Crigler-Najjar syndrome – Basic Information Marginal zone lymphoma refractory KBG syndrome – Life with Disease Hereditary motor and sensory neuropathy – Basic Information Urea cycle disorder – Life with Disease Stevens-Johnson syndrome Niemann-Pick disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aprepitant Tirbanibulin Dasatinib Sodium Alginate Miransertib Tx200-Tr101 Vibostolimab Siponimod Ibutamoren Mesilate Xtmab-16 Mecasermin Rinfabate Ampicillin Sodium Phenylalanine Topotecan Hydrochloride Thymalfasin METAMIZOLE SODIUM Mk-1942 RO7268489 ZINC Citicoline Sodium More therapies…

    Learn about Your Condition

    Hepatotoxicity Stem cell transplant Breast cancer Urticaria chronic Aphthous ulcer Hernia repair Vascular malformation Hypoparathyroidism Glaucoma Spina bifida Biliary cancer metastatic Wheezing Proteinuria Cardiac valve disease Alcoholic liver disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Propofol and Remifentanil for Patients with Heart Disease Undergoing Cardiac Anesthesia with Cardiopulmonary Bypass

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic disorder
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Remifentanil
    • Propofol
    Austria

  • Study on the Safety and Effectiveness of LIS1 for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

    Recruiting

    1 1 1
    Investigated Diseases:
    • T-cell lymphoma
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Pig
    France Italy

  • Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    Italy

  • Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Doxorubicin Hydrochloride
    Austria Belgium France Germany Portugal Spain

  • Study on the Use of Mesenchymal Stem Cells and Sodium Chloride for Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    • Sodium Chloride
    Norway

  • Study on Metformin and Lifestyle Changes for Girls with Early Puberty and Overweight

    Recruiting

    2 1 1
    Investigated Diseases:
    • Precocious puberty
    • Overweight
    Investigated Drugs:
    • Metformin Hydrochloride
    Denmark
Previous Page
1 … 476 477 478 479 480 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!